Deargen
Deargen Inc. | Deargen Inc.
Seoul, South Korea · Founded 2016
- Headquarters
- Seoul
- Founded
- 2016
- Business Model
- B2B
- Website
- deargen.me
About
Deargen is an AI-first pharmatech company that uses its Dr. UG platform to support drug discovery and development. The platform applies deep-learning technology to genome-data analysis, biomarker prediction, target discovery, molecule selection, and lead optimization. Deargen uses these capabilities to identify disease targets and design small-molecule candidates for precision-medicine programs.
Summary
Deargen is an Artificial Intelligence company based in Seoul, South Korea, founded in 2016.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/deargen"><img src="https://indexed.vc/api/badge/company/deargen" alt="Deargen on Indexed.vc" width="260" height="76" /></a>